Abstract

Introduction: The mechanism of enhanced atrioventricular nodal conduction (EAVNC), including Lown-Ganong-Levine (LGL) syndrome, is not well described. Transgenic mice with the over-expression SCN5A results in a shorter P-R interval; hence, we tested the hypothesis that overexpression of SCN5A may provide an animal model mimicking EAVNC. Methods: Electrocardiogram (ECG), atrial, His-bundle and ventricular electrograms were recorded from wild type (WT) and transgenic mice over-expressing SCN5A (TG). Peak Na + current (I Na ) and Nav1.5 expression were measured using patch-clamp technique and immunohistochemistry method, respectively. Results: P-R interval in TG was much shorter than in WT mice (13.6±1.20 vs. 40.2±0.59 ms, n=20 and 35). In TG isolated hearts the A-V conduction during right atrial pacing remains shorter than that of WT isolated hearts (14.4±0.81 vs. 39.5±0.62 ms, n=28 each). His-bundle electrogram (HBE) revealed a short A-H and H-V intervals in TG, compared to WT mice (Figure 1A-D). In addition, TG mice had a short Wenckebach cycle length (CL) and atrioventricular effective refractory period (AVERP). Peak I Na was 2-fold greater in TG compared to WT ventricular myocytes (198.2±16.22 vs. 89.6±5.35 pA/pF, n=12). Flecainide (6 μM, n=6) led to prolongation of A-V conduction time in TG to a value close to that of WT hearts. Nifedipine (1 μM, n=) prolonged A-H interval in WT but not in TG hearts. Immunohistochemistry studies revealed increased Nav1.5 labeling in TG atrial and ventricular tissue, and Nav1.5 expression in A-V junction and A-V ring regions of TG compared to WT hearts. Conclusion: SCN5A over expression in TG mice enhanced the A-V conduction mimicking EAVNC. Thus, higher level of sodium channel expression in the A-V nodal region may be an electrophysiological substrate responsible for the syndrome of EAVNC. Figure 1

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.